Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells

Cancer Science

Volumn 98, Issue 11, 2007, Pages 1767-1774

  Li, Qing Quan ^a   Wang, Wen Juan ^a   Xu, Jing Da ^a   Cao, Xi Xi ^a   Chen, Qi ^a   Yang, Jin Ming ^a   Xu, Zu De ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BLEOMYCIN; CD147 ANTIGEN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; GLYCOPROTEIN P; PACLITAXEL; VINCRISTINE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CANCER SURVIVAL; CELL INVASION; CELL STRAIN MCF 7; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; METASTASIS POTENTIAL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANTIGENS, CD; ANTIGENS, CD147; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34748848072     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00593.x     Document Type: Article

References (22)

1. Kerbel RS, Waghorne C, Korczak B, Lagarde A, Breitman ML. Clonal dominance of primary tumours by metastatic cells: Genetic analysis and biological implications. Cancer Surv 1988; 7:597-629.
2. Kerbel RS, Korczak B, Lagarde A. Growth dominance of the metastatic cancer cell: Cellular and molecular aspects. Adv Cancer Res 1990; 5: 87-132.
3. Su ZZ, Austin VN, Zimmer SG, Fisher PB. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha- ras -transformed cloned rat embryo fibroblast cells. Oncogene 1993; 8: 1211-19.
4. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene 2003; 22: 7468-85.
5. Yang JM, Yang GY, Medina DJ, Vassil AD, Liao J, Hait WN. Treatment of multidrug resistant (MDR1) murine leukemia with P-glycoprotein substrates accelerates the course of the disease. Biochem Biophys Res Commun 1999; 266: 167-73.
6. Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003; 1: 420-7.
7. Yan LS, Zucker BP. Toole. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 2005; 93: 199-204.
8. Menashi S, Serova M, Ma L, Vignot S, Mourah S, Calvo F. Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res 2003; 63: 7575-80.
9. Yang J-M, Gregory FS, William H IV. Regulation of the function of P-glycoprotein by epidermal growth factor through phospholipase C. Biochem Pharmacol 1997; 53: 1597-604.
10. Davies R, Budworth J, Riley J, Snowden R, Gescher A, Gant TW. Regulation of P-glycoprotein 1 and 2 gene expression and protein activity in two MCF7/ADR cell line subclones. Br J Cancer 1996; 73: 307-15.
11. Guerrero J, Santibanez JF, Gonzalez A, Martinez J. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp Cell Res 2004; 292: 201-8.
12. Suzuki S, Sato M, Senoo H, Ishikawa K. Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and broblasts: Involvement EMMPRIN and Mt1-MMP. Exp Cell Res 2004; 293: 259-66.
13. Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is system with an improved hairpin and its significant expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002; 99: 520-8.
14. Bordador LC, Li X, Toole B et al. Expression of emmprin by oral squamous cell carcinoma. Int J Cancer 2000; 85: 347-52.
15. Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clin Exp Metastasis 2003; 20: 161-9.
16. Shi Y, Ouyang P, Sugrue SP. Characterization of the gene encoding pinin/ DRS/memA and evidence for its potential tumor suppressor function. Oncogene 2000; 19: 289-97.
17. Li Q-Q, Wang W-J, Xu Z-D et al. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Sci 2007; 98: 1064-9.
18. Aszalos A, Ross D. Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs. Anticancer Res 1998; 18: 2937-44.
19. Larsen A, Escargueil A, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000; 85: 217-29.
20. Gwendalyn JR, Sylvie B, Melissa P et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci 1998; 95: 6924-9.
21. Weinstein RS, Jakate SM, Dominguez JM et al. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991; 51: 2720-6.
22. Emanuel SL, Chamberlin HA, Cohen D. Antimitotic drugs cause increased tumorigenicity of multidrug resistant cells. Int J Oncol 1999; 14: 487-94.